What are the current challenges in Bioprocessing?

Here at the Bioprocessing International European Summit, we asked a number of leading industry experts from across all sectors of the industry what are the biggest challenges they are currently facing in their work, and what is being done to resolve and overcome these challenges.

Parrish Galliher, Chief Technology Officer for Upstream, GE Healthcare outlines his thoughts on current challenges.

Continue reading “What are the current challenges in Bioprocessing?”

LISTEN: Melema Single-Use Mass Flow Meter

In the latest product podcast, Alan Young, CTO of Malema Sensors in California takes you through their family of single use flow meters, and for anyone who is using a flow meter right now or may need one, I think you’ll find this very interesting.

Continue reading “LISTEN: Melema Single-Use Mass Flow Meter”

Bringing it all Together for Commercialisation Pt.2

Brian Caine, co-founder and publisher of Bioprocess International Magazine sets out the topic of discussion for the fireside chat, “Bringing it all Together for Commercialisation – perspectives from every stage” and introduces the panel of experts, with conservatively over 100 years of experience between them,

Opening the discussion, Brian explores the problem of cost and time inefficiencies currently causing the industry pain.

Continue reading “Bringing it all Together for Commercialisation Pt.2”

The Story of BPI Europe 2016 in Photos

The BioProcess International European Summit 2016 took place in Vienna last week. We’ve gathered together some of the best photos from the conference; if you were there, this is your chance to relive it; if you weren’t, then see what you missed.

Continue reading “The Story of BPI Europe 2016 in Photos”

WATCH: Highlights from BPI Europe 2016

After a fantastic week in Vienna, we’re back from this year’s BioProcess International Europe. A very big thank you to everyone who attended; it was great seeing so many familiar faces, as well as meeting lots of new ones. Try and spot yourself in the highlights video above, or if you couldn’t make it, see what you missed out on and hopefully we’ll see you next year.

Continue reading “WATCH: Highlights from BPI Europe 2016”

Vienna Area Guide: Restaurants & Points of Interest Near BioProcess International European Summit

With less than a week until the BioProcess International European Summit in Vienna, we have put together a handy guide to the restaurants, places of interest and taxis in the area. We hope you find these recommendations useful during your time spent in the city.

Casual Restaurants

Wohlmutstueberl

Wohlmutstrasse 23, Vienna 1020
Phone Number: 676 35 95 174

This restaurant can be found just 500m from the conference venue, and can be walked in 6 minutes. The Wohlmutstueberl “combines traditional Viennese cuisine with delicacies for the health conscious” and has an extensive a la carte menu that can be viewed here.

Continue reading “Vienna Area Guide: Restaurants & Points of Interest Near BioProcess International European Summit”

From Molecular Medicine to Patient: A Success Story Called RANKL

At the Institute of Molecular Biotechnology (IMBA) in Austria, 13 independent groups work on various research topics in genetics and biomedicine. One of the key focus areas of Josef Penninger, scientific director of IMBA, is the various functions of the membrane protein RANKL – from its discovery, to the development of a new drug, which is now prescribed to thousands of patients every year.

Penninger was the first to find genetic evidence that RANKL is the master regulator of adequate bone metabolism by activating osteoclasts, which are critically involved in bone resorption. Overexpression of RANKL is implicated in a variety of degenerative bone diseases such as osteoporosis. RANKL is also known for acting on breast, prostate and skin cancer cells through the RANK receptor.

EXPLORE: See Joseph Penninger speak at BioProcess International Europe on 12th April in Vienna – find out more and register here

Continue reading “From Molecular Medicine to Patient: A Success Story Called RANKL”